Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Join us for the ORS 2025 Annual Meeting, taking place February 7-11, 2025 in Phoenix, Arizona at the Phoenix Convention Center. The meeting will bring the orthopaedic community together for five days of scientific education, workshops, networking, exhibits, poster sessions, and much more. Attendees of all career levels from many disciplines will gather to network and learn about the latest innovations in orthopaedics.
Join us at ORS 2025! We can’t wait to see you there.
When does the Meeting Take Place?
February 7 – 11
Phoenix Convention Center
Phoenix, AZ
We’ll be hosting a 15-minute spotlight at ORS 2025!Â
Title: Assessing Precision and Accuracy of the iNSiGHT DEXA: Validation Against Gold-Standard Techniques
Speaker: Jade Marrow​
Description: This workshop explores research and peer-reviewed studies validating the iNSiGHT DEXA against other DEXA systems, NMR, and chemical analysis, positioning it as the ideal tool for your next study. The iNSiGHT DEXA is the only preclinical system available that has been fully validated against chemical carcass analysis, ashing, and scale weight, demonstrating strong correlation with gold-standard techniques. With a quick 25-second in vivo scan time and exceptional precision, the iNSiGHT DEXA offers researchers an efficient and accurate method for long-term monitoring of body and bone composition changes.
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders